4//SEC Filing
Lawrence Ira D 4
Accession 0001250023-05-000014
CIK 0000880771other
Filed
Jun 2, 8:00 PM ET
Accepted
Jun 3, 4:45 PM ET
Size
8.2 KB
Accession
0001250023-05-000014
Insider Transaction Report
Form 4
Lawrence Ira D
Director
Transactions
- Award
Non-Qualified Stock Option (right to buy)
2005-06-01+400,000→ 400,000 totalExercise: $2.97Exp: 2015-06-01→ Common Stock (400,000 underlying)
Footnotes (3)
- [F1]Granted under the Issuer's 2004 Stock Option Plan.
- [F2]Provided the reporting person remains employed by the Company, the option will become exercisable in four equal annual installments on 6/01/06, 6/01/07, 6/01/08 and 6/01/09.
- [F3]Provided the reporting person remains employed by the Company, the option will become exercisable in four equal installments upon the attainment of certain stock trading price goals and each such installment will terminate if the goal is not attained during the requisite periods ending 6/01/08, 6/01/09, 6/01/10 and 6/01/11.
Documents
Issuer
SCICLONE PHARMACEUTICALS INC
CIK 0000880771
Entity typeother
Related Parties
1- filerCIK 0001328576
Filing Metadata
- Form type
- 4
- Filed
- Jun 2, 8:00 PM ET
- Accepted
- Jun 3, 4:45 PM ET
- Size
- 8.2 KB